Medicure Inc.
MCUJF
$0.82
-$0.0099-1.19%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -3.45% | -0.57% | -8.82% | -10.81% | -7.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.45% | -0.57% | -8.82% | -10.81% | -7.06% |
| Cost of Revenue | 17.78% | 16.40% | 33.35% | 18.40% | 9.25% |
| Gross Profit | -15.64% | -9.89% | -27.17% | -23.35% | -14.41% |
| SG&A Expenses | -4.54% | 0.95% | 2.91% | 4.35% | 2.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.07% | 8.92% | 14.80% | 10.62% | 2.56% |
| Operating Income | -136.84% | -254.36% | -447.45% | -244.63% | -270.31% |
| Income Before Tax | -33.02% | 13.91% | -270.22% | -213.04% | -194.96% |
| Income Tax Expenses | 413.32% | 875.79% | 98.29% | 25.88% | 420.00% |
| Earnings from Continuing Operations | -49.50% | -11.23% | -286.40% | -221.16% | -197.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -49.50% | -11.23% | -286.40% | -221.16% | -197.95% |
| EBIT | -136.84% | -254.36% | -447.45% | -244.63% | -270.31% |
| EBITDA | -633.97% | -240.89% | -182.46% | -131.42% | -88.37% |
| EPS Basic | -49.39% | -11.68% | -284.50% | -219.40% | -196.45% |
| Normalized Basic EPS | -138.46% | -227.44% | -469.28% | -247.61% | -269.72% |
| EPS Diluted | -49.82% | -10.25% | -302.09% | -225.49% | -203.05% |
| Normalized Diluted EPS | -136.91% | -223.29% | -475.47% | -249.94% | -275.71% |
| Average Basic Shares Outstanding | 0.00% | 0.34% | 0.78% | 1.24% | 1.69% |
| Average Diluted Shares Outstanding | -3.26% | -2.98% | -2.98% | 3.07% | 3.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |